17.64
price down icon1.89%   -0.34
after-market After Hours: 18.00 0.36 +2.04%
loading
Corbus Pharmaceuticals Holdings Inc stock is traded at $17.64, with a volume of 154.83K. It is down -1.89% in the last 24 hours and up +8.15% over the past month. Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$17.98
Open:
$17.93
24h Volume:
154.83K
Relative Volume:
0.24
Market Cap:
$216.67M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-1.6036
EPS:
-11
Net Cash Flow:
$-36.86M
1W Performance:
+9.70%
1M Performance:
+8.15%
6M Performance:
-60.82%
1Y Performance:
+319.00%
1-Day Range:
Value
$17.54
$18.15
1-Week Range:
Value
$16.08
$18.43
52-Week Range:
Value
$4.06
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Name
Corbus Pharmaceuticals Holdings Inc
Name
Phone
617-963-0103
Name
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Employee
19
Name
Twitter
@corbuspharma
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
CRBP's Discussions on Twitter

Compare CRBP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
17.64 216.67M 1.54M -38.70M -36.86M -11.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
464.56 119.70B 10.63B -479.80M -1.35B 13.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
754.87 82.75B 13.85B 4.65B 3.32B 35.06
Biotechnology icon
ARGX
Argen X Se Adr
614.59 36.73B 1.86B -40.29M -1.28B -4.16
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.74 32.53B 2.09B -332.26M 16.06M -4.14
Biotechnology icon
BNTX
Biontech Se Adr
120.72 28.50B 3.30B -501.07M 1.03B 11.54

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-30-24 Initiated Wedbush Outperform
Jul-22-24 Resumed H.C. Wainwright Buy
Jun-26-24 Initiated B. Riley Securities Buy
Jun-03-24 Reiterated Oppenheimer Outperform
May-13-24 Initiated RBC Capital Mkts Outperform
Mar-06-24 Upgrade Jefferies Hold → Buy
Sep-08-20 Downgrade BTIG Research Buy → Neutral
Sep-08-20 Downgrade Jefferies Buy → Hold
Sep-08-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Sep-08-20 Downgrade ROTH Capital Buy → Neutral
Jul-07-20 Initiated ROTH Capital Buy
Jun-17-20 Initiated BTIG Research Buy
Mar-26-20 Initiated Nomura Buy
Apr-05-19 Initiated Jefferies Buy
Mar-20-19 Initiated Oppenheimer Outperform
Jan-11-19 Reiterated Cantor Fitzgerald Overweight
Dec-26-18 Initiated H.C. Wainwright Buy
Dec-07-18 Initiated RBC Capital Mkts Outperform
Oct-24-18 Initiated B. Riley FBR Buy
Jan-19-18 Initiated Raymond James Outperform
Dec-14-17 Reiterated Cantor Fitzgerald Overweight
Nov-08-17 Reiterated Noble Financial Buy
Sep-29-17 Resumed Noble Financial Buy
Mar-30-17 Reiterated Cantor Fitzgerald Overweight
Nov-15-16 Reiterated JMP Securities Mkt Outperform
Nov-11-16 Reiterated Noble Financial Buy
View All

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News

pulisher
Nov 26, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

Nov 26, 2024
pulisher
Nov 26, 2024

Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now - Insider Monkey

Nov 26, 2024
pulisher
Nov 25, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 25, 2024
pulisher
Nov 25, 2024

CRBP (Corbus Pharmaceuticals Holdings) Change In Working Ca - GuruFocus.com

Nov 25, 2024
pulisher
Nov 24, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 24, 2024
pulisher
Nov 21, 2024

CRBPCorbus Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference - The Manila Times

Nov 21, 2024
pulisher
Nov 21, 2024

Corbus Pharmaceuticals to Present at Evercore HealthCONx Conference in December | CRBP Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 20, 2024
pulisher
Nov 19, 2024

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 19, 2024
pulisher
Nov 17, 2024

Corbus Pharmaceuticals director sets plan for stock sale - Investing.com India

Nov 17, 2024
pulisher
Nov 16, 2024

(CRBP) Investment Report - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 16, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Update - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

OrbiMed Advisors LLC Acquires New Stake in Corbus Pharmaceuticals Holdings Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Corbus Pharmac - GuruFocus.com

Nov 15, 2024
pulisher
Nov 12, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 12, 2024
pulisher
Nov 12, 2024

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Corbus Pharmaceuticals to Present at Jefferies London Healthcare Conference | CRBP Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Nov 11, 2024
pulisher
Nov 11, 2024

Brokers Set Expectations for CRBP Q1 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha

Nov 11, 2024
pulisher
Nov 09, 2024

We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 08, 2024
pulisher
Nov 08, 2024

Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Corbus Pharmaceuticals: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 07, 2024
pulisher
Nov 07, 2024

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Corbus Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 06, 2024

(CRBP) On The My Stocks Page - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Corbus Pharmaceuti - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Corbus Pharmaceuticals' (CRBP) Outperform Rating Reaffirmed at Wedbush - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024 - The Manila Times

Nov 04, 2024
pulisher
Nov 02, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $65.86 Consensus PT from Analysts - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Grows By 5.8% - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $65.86 Consensus Price Target from Brokerages - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - The Manila Times

Oct 29, 2024
pulisher
Oct 28, 2024

Corbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market - MarketWatch

Oct 28, 2024

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):